Treadwell Announces Initiation of Patient Dosing in TWT-203, a Phase 1b/2 study of TTK Inhibitor, CFI-402257, in Patients with ER+/Her2- Breast cancer

PR Newswire
June 14, 2022 — 04:01 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: biotech Hong Kong New York United States

Related News:

Inaugural ‘Korea Medical Innovation Research Forum’ regular seminar, a success

April 19, 2024 — 21:00

Tianliculum: Customizing Your Educational "Menu"

April 19, 2024 — 09:03

Automation Anywhere Earns 2024 Great Place To Work Certification™

April 18, 2024 — 22:00

Bridgewise secures $21 million in new funding to support the global expansion of its AI-powered financial intelligence platform for global securities

April 16, 2024 — 12:01

International Film Camp Awards Winners

April 15, 2024 — 14:19

IOT Data Hackathon Award Ceremony – Data-driven Economy: Unleashing the Powerhouse of Possibilities

April 13, 2024 — 18:30

Goldpac Exhibits at InnoEx 2024

April 13, 2024 — 10:00

Dachser acquires food logistics provider Brummer

April 11, 2024 — 10:00

St. Joseph’s Children’s Hospital Foundation Receives Historic $50 Million Gift from the Pagidipati Family of Tampa

April 11, 2024 — 09:18